ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "An Next Generation Sequencing Approach to Influenza Vaccine Development"
Episode Synopsis
In this episode, Dr. Wayne Hogrefe and Dr. Pat Hurban discuss the use of NGS in the development and assessment of new vaccines against the influenza virus.
Topics covered include:
What health organizations are looking for that drives the selection of the next season's vaccine strains
How sequence data is used to evaluate the effectiveness of a vaccine while providing insight into the evolution of the virus
How the sequence data can inform the development of new types of vaccines and therapeutics
The prospects for a vaccine that is effective across multiple strains and multiple seasons
How NGS data differs from traditional Sanger sequencing data and what can be learned from that
You can learn more about this topic at www.q2labsolutions.com
Topics covered include:
What health organizations are looking for that drives the selection of the next season's vaccine strains
How sequence data is used to evaluate the effectiveness of a vaccine while providing insight into the evolution of the virus
How the sequence data can inform the development of new types of vaccines and therapeutics
The prospects for a vaccine that is effective across multiple strains and multiple seasons
How NGS data differs from traditional Sanger sequencing data and what can be learned from that
You can learn more about this topic at www.q2labsolutions.com
More episodes of the podcast Laboratory Considerations for Clinical Trials
Managing Sample Data from Vendors
14/09/2021
Automation within an ADME Laboratory
26/08/2021
Bioanalytical Automation of Samples
30/07/2021
In God we trust